ADA: T1D, T2D, GDM Before 26 Weeks Tied to Higher ASD Risk
Study shows increased risks of autism spectrum disorder in association with types 1, 2, gestational diabetes.
ADA 78th Scientific Sessions 2018
Cardiovascular Outcomes in Patients With ACS, Diabetes Using Alirocumab
Investigators examine the effects of the PCSK9 inhibitor alirocumab in patients with recent acute coronary syndrome and diabetes.
Dual-Hormone Artificial Pancreas Reduces Glucose Variability in T1D
Investigators conducted a randomized crossover comparison of 2 dual-hormone artificial pancreas systems — one with rapid insulin and amylin, and another with regular insulin and amylin — with a rapid insulin-alone artificial pancreas.
Improved Glycemic Control With Closed-Loop Insulin Delivery System
Researchers conducted a randomized, open-label trial to assess the effect of an automated closed-loop insulin delivery system on glycemic control in hospitalized patients.
Technosphere Inhaled Insulin Improves Glycemic Control in Type 1 Diabetes
Patients were randomly assigned to receive insulin aspart or Technosphere inhaled insulin.
Safety and Performance of Omnipod HCL for Children With Type 1 Diabetes
In children with type 1 diabetes, the Omnipod hybrid closed-loop personal model system was safe and performed well.
Pen vs Patch Bolus Insulin Delivery for T2D Using CGM
Investigators compared 2 methods of delivering bolus insulin, pen vs patch, using metrics from continuous glucose monitoring.
Empagliflozin, Liraglutide Reduce Cardiovascular Mortality Risk
Investigators conducted a meta-analysis to compare the efficacy of SGLT2i, DPP-4i, and GLP-1 agonists for reducing cardiovascular outcomes.
Type 2 Diabetes Does Not Affect Pneumonia Incidence, Outcomes After Stroke
Investigators examined the incidence and outcomes of pneumonia in patients with acute ischemic stroke and type 2 diabetes.
Risk for Below Knee Amputations With Canagliflozin vs Other Antihyperglycemic Agents
Investigators analyzed real world data to examine the risk for below-knee amputations in patients with type 2 diabetes taking canagliflozin vs other medications.
Want to read more?
Please login or register first to view this content.
Next post in ADA 78th Scientific Sessions 2018
